Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Taylor

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Stroke|November 1, 1990
Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in ratP A Boxer, J J Cordon, M E Mann, et al.
Journal of Medicinal Chemistry|October 30, 1992
Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptakeM R Pavia, S J Lobbestael, D Nugiel, et al.
Epilepsy Research|April 29, 1998
A summary of mechanistic hypotheses of gabapentin pharmacologyC P Taylor, N S Gee, T Z Su, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonistsT R Ryder, L Y Hu, M F Rafferty, et al.
Bioorganic & Medicinal Chemistry|July 15, 2000
The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phen yl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesiaL Y Hu, T R Ryder, M F Rafferty, et al.
Drug Design and Discovery|May 12, 2000
Structure-activity relationship at the leucine side chain in a series of N,N-dialkyldipeptidyl-amines as N-type calcium channel blockersT R Ryder, L Y Hu, M F Rafferty, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Journal of Medicinal Chemistry|October 9, 1999
Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic propertiesL Y Hu, T R Ryder, M F Rafferty, et al.
Drug Design and Discovery|August 6, 2000
Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activityL Y Hu, T R Ryder, M F Rafferty, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Stroke|November 1, 1990
Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in ratP A Boxer, J J Cordon, M E Mann, et al.
Journal of Medicinal Chemistry|October 30, 1992
Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptakeM R Pavia, S J Lobbestael, D Nugiel, et al.
Epilepsy Research|April 29, 1998
A summary of mechanistic hypotheses of gabapentin pharmacologyC P Taylor, N S Gee, T Z Su, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonistsT R Ryder, L Y Hu, M F Rafferty, et al.
Bioorganic & Medicinal Chemistry|July 15, 2000
The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phen yl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesiaL Y Hu, T R Ryder, M F Rafferty, et al.
Drug Design and Discovery|May 12, 2000
Structure-activity relationship at the leucine side chain in a series of N,N-dialkyldipeptidyl-amines as N-type calcium channel blockersT R Ryder, L Y Hu, M F Rafferty, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockersL Y Hu, T R Ryder, M F Rafferty, et al.
Journal of Medicinal Chemistry|October 9, 1999
Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic propertiesL Y Hu, T R Ryder, M F Rafferty, et al.
Drug Design and Discovery|August 6, 2000
Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activityL Y Hu, T R Ryder, M F Rafferty, et al.
Pageof 8